Effects of Anti-Histamine Treatment on Liver Injury Triggered by Small Intestinal Ischemia Reperfusion in Rats

10.4077/CJP.2014.BAC230

Pin-Jie Huang；Xiao-Liang Gan；Jian-Pei Liu；De-Zhao Liu；Yan-Ling Wang；Zi-Qing Hei

histamine ； intestinal ； ischemia reperfusion ； liver injury ； mast cell degranulation

The Chinese Journal of Physiology

57卷5期（2014 / 10 / 31）

271 - 278

繁體中文

Mast cell (MC) degranulation has been implicated in small intestinal ischemia reperfusion (IIR) injury, therein, inhibiting overproduction of histamine released from activated MC may provide promising strategies against IIR-mediated liver injuries. The aim of the present study was to explore whether anti-histamine treatment contribute to attenuating IIR-mediated liver injury. Adult SD rats were randomized into sham-operated group (S group), sole IIR group (IIR group), and IIR treated with Ketotifen, a histamine antagonist (IIR+K group), Cromolyn Sodium, a MC stabilizer (IIR+C group), and Compound 48/80, a MC degranulator (IIR+CP group), respectively. IIR was induced by superior mesenteric artery occlusion for 75 min followed by 4 h of reperfusion. The agents were intravenously administrated 5 min before reperfusion to induce different levels of histamine. Subsequently, serum concentrations of ALT, AST and histamine; levels of LDH,TNF-α, IL-8 and MDA as well as SOD activities in the liver were assessed. Histopathologic changes were also evaluated. IIR resulted in severe liver injury as demonstrated by significant increases in injury scores, with concomitant significant increases in serum ALT, AST and histamine levels, as well as LDH, TNF-α, IL-8, and MDA levels in the liver, accompanied by reduction in SOD activities (all P ＜ 0.05, IIR vs. S). Treatments by Ketotifen and Cromolyn Sodium similarly markedly alleviated IIR-mediated liver injury as confirmed by significant reduction of the above biomedical changes whereas Compound 48/80 further aggravated IIR-mediated liver injury by dramatically enhancing the above biomedical changes. Data of our study suggest that anti-histamine treatments may provide promising benefits in alleviating liver injury triggered by IIR.

1. Chang, C.C.,Chang, C.Y.,Huang, J.P.,Hung, L.M.(2012).Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats.Chinese J. Physiol,55,192-201.
   連結：
2. Krauss, H.,Sosnowski, P.,Biczysko, M.,Biczysko, W.,Majewski,P.,Jablecka, A.,Miskowiak, B.,Smolarek, I.,Konwerska, A.,Ignys, I.,Micker, M.(2011).Effects of L-arginine and NG-nitro Larginine methyl ester (L-NAME) on ischemia/reperfusion injury of skeletal muscle, small and large intestines.Chinese J. Physiol.,54,7-18.
   連結：
3. Lin, H.I.,Wang, D.,Leu, F.J.,Chen, C.F.,Chen, H.I.(2004).Ischemia and reperfusion of liver induces eNOS and iNOS expression: effects of a NO donor and NOS inhibitor.Chinese J. Physiol,47,121-127.
   連結：
4. Lu, X.M.,Zhao, H.,Zhang, H.P.(2013).Role of neuronal nitric oxide synthase in the cardiac ischemia reperfusion in mice.Chinese J. Physiol,56,291-297.
   連結：
5. Agostino, P.,Simon, E.(2004).Intestinal ischemia reperfusion injury and multisystem organ failure.Semin. Pediatr. Surg,13,11-17.
6. Akdis, C.A.,Simons, F.E.(2006).Histamine receptors are hot in immunopharmacology.Eur. J. Pharmacol,533,69-76.
7. Armbrust, T.,Batusic, D.,Ringe, B.,Ramadori, G.(1997).Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis.J. Hepatol,26,1042-1054.
8. Bachert, C.,Maspero, J.(2011).Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma.J. Asthma.,48,965-973.
9. Boros, M.,Ordogh, B.,Kaszaki, J.,Nagy, S.(1999).The role of mast cell degranulation in ischaemia-reperfusion-induced mucosal injury in the small intestine.Ann. Acad. Med. Singapore,28,79-84.
10. Enoksson, M.,Lyberg, K.,Möller-Westerberg, C.,Fallon, P.G.,Nilsson, G.,Lunderius-Andersson, C.(2011).Mast cells as sensors of cell injury through IL-33 recognition.J. Immunol,186,2523-2528.
11. Frangogiannis, N.G.,Youker, K.A.,Rossen, R.D.,Gwechenberger,M.,Lindsey, M.H.,Mendoza, L.H.,Michael, L.H.,Ballantyne,C.M.,Smith, C.W.,Entman, M.L.(1998).Cytokines and the microcirculation in ischemia and reperfusion.J. Mol. Cell. Cardiol.,30,2567-2576.
12. Grant, S.M.,Goa, K.L.,Fitton, A.,Sorkin, E.M.(1990).Ketotifen: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.Drugs,40,412-448.
13. Hakan, C.,Tamer, A.,Canten, T.(2007).The effects of exogenous l-carnitine on lipid peroxidation and tissue damage in an experimental warm hepatic ischemia-reperfusion injury model.Curr. Ther. Res. Clin. Exp.,68,32-46.
14. Harward, T.R.,Brooks, D.L.,Flynn, T.C.,Seeger, J.M.(1993).Multiple organ dysfunction after mesenteric artery revascularization.J. Vasc. Surg.,18,459-469.
15. Hei, Z.Q.,Huang, P.J.,Gan, X.L.,Pang, H.Y.,Wei, J.(2008).Influence of Cromolyn Sodium and compound 48/80 administered prior to and after reperfueion on the third day's survival rate in a rat intestinal ischemia model.Chinese Medical Journal,121,1843-1847.
16. Huang, P.J.,Liu, D.Z.,Gan, X.L.,Zhang, R.,Gao, W.,Xia, Z.Y.,Hei, Z.Q.(2012).Mast cells activation contribute to small intestinal ischemia reperfusion induced acute lung injury in rats.Injury,43,1250-1256.
17. Kalia, N.,Brown, N.J.,Wood, R.F.,Pockley, A.G.(2005).Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury.J. Gastroenterol. Hepatol,20,1032-1038.
18. Kaszaki, J.,Boros, M.,Szabo, A.,Nagy, S.(1994).Role of histamine in the intestinal flow response following mesenteric ischemia.Shock,2,413-420.
19. Mallick, I.H.,Yang, W.,Winslet, M.C.,Seifalian, A.M.(2004).Ischemiareperfusion injury of the intestine and protective strategies against injury.Dig. Dis. Sci.,49,1359-1377.
20. Masaki, T.,Chiba, S.,Tatsukawa, H.,Noguchi, H.,Kakuma, T.,Endo, M.,Seike, M.,Watanabe, T.,Yoshimatsu, H.(2005).The role of histamine H1 receptor and H2 receptor in LPS-induced liver injury.FASEB. J.,19,1245-1252.
21. Olanders, K.,Sun, Z.,Brjesson, A.,Dib, M.,Andersson, E.,Lasson, A.,Ohlsson, T.,Andersson, R.(2002).The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats.Shock,18,86-92.
22. Rangachari, P.K.(1992).Histamine: mercurial messenger in the gut.Am. J. Physiol,262,G1-G13.
23. Sheng, Z.Y.,Dong, Y.L.,Wang, X.H.(1991).Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion.Chines Med. J. (Engl),104,897-903.
24. Sun, W.Y.,Abeynaike, L.D.,Escarbe, S.,Smith, C.D.,Pitson, S.M.,Hickey, M.J.,Bonder, C.S.(2012).Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent.Am. J. Pathol,180,1740-1750.
25. Tagen, M.,Elorza, A.,Kempuraj, D.,Boucher, W.,Kepley, C.L.,Shirihai, O.S.,Theoharides, T.C.(2009).Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content.J. Immunol.,183,6313-6319.
26. Tomita, M.,Kishimoto, H.,Takizawa, Y.,Hayashi, M.(2009).Effects of intestinal ischemia/reperfusion on P-glycoprotein mediated biliary and renal excretion of rhodamine123 in rat.Drug. Metab. Pharmacokinet,24,428-437.
27. Turnage, R.H.,Bagnasco, J.,Berger, J.,Guice, K.S.,Oldham, K.T.,Hinshaw, D.B.(1991).Hepatocellular oxidant stress following intestinal ischemia-reperfusion injury.J. Surg. Res.,51,467-471.
28. Vural, K.M.,Liao, H.,Oz, M.C.,Pinsky, D.J.(2000).Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model.Ann. Thorac. Surg.,69,228-232.
29. Wu, T.S.,Gan, X.L.,Zhou, S.L.,Ge, M.,Zhang, Z.,Hei, Z.Q.(2013).Histamine at low concentrations aggravates rat liver BRL-3A cell injury induced by hypoxia/reoxygenation through histamine H2 receptor in vitro.T. Toxicol. In. Vitro.,27,378-386.
30. Yamashiro, M.,Kouda, W.,Kono, N.,Tsuneyama, K.,Matsui, O.,Nakanuma, Y.(1998).Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study.Virchows. Arch,433,471-479.
31. Yao, J.H.,Li, Y.H.,Wang, Z.Z.,Zhang, X.S.,Wang, Y.Z.,Yuan, J.C.,Zhou, Q.,Liu, K.X.,Tian, X.F.(2007).Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.Clin. Exp. Pharmacol. Physiol.,34,1102-1108.
32. Yao, J.H.,Zhang, X.S.,Zheng, S.S.,Li, Y.H.,Wang, L.M.,Wang, Z.Z.,Chu, L.,Hu, X.W.,Liu, K.X.,Tian, X.F.(2009).Prophylaxis with carnosol attenuates liver injury induced by intestinal ischemia/reperfusion.World J. Gastroenterol,15,3240-3245.